EZH2 and hepatocellular carcinoma: A previously report showed that EZH2 expression was upregulated in HCC and that silencing EZH2 inhibited HCC viability, migration, and invasion, increased E-cadherin expression, and decreased N-cadherin and waveform protein expression35.